Viemed Healthcare (VMD) Net Income towards Common Stockholders (2018 - 2026)

Viemed Healthcare's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders changed 0.11% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (up 22.87% YoY) and the FY2025 annual result came in at $15.4 million, up 34.77% from the prior year.
• Net Income towards Common Stockholders was $2.7 million for Q1 2026 at Viemed Healthcare, down from $5.8 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.8 million in Q4 2025 and bottomed at $967000.0 in Q2 2022.
• A 5-year average of $2.7 million and a median of $2.7 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 41.03% — and 2023, when it surged 176.68%.
• Viemed Healthcare's Net Income towards Common Stockholders stood at $2.4 million in 2022, then surged by 42.62% to $3.5 million in 2023, then climbed by 27.24% to $4.4 million in 2024, then surged by 31.46% to $5.8 million in 2025, then plunged by 53.35% to $2.7 million in 2026.
• Business Quant data shows VMD's Net Income towards Common Stockholders at $2.7 million in Q1 2026, $5.8 million in Q4 2025, and $3.6 million in Q3 2025.